<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83281">
  <stage>Registered</stage>
  <submitdate>20/10/2008</submitdate>
  <approvaldate>12/05/2009</approvaldate>
  <actrnumber>ACTRN12609000244202</actrnumber>
  <trial_identification>
    <studytitle>Prospective risk assessment of bacteraemia and other infectious complications in patients undergoing Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)</studytitle>
    <scientifictitle>Prospective risk assessment of bacteraemia and other infectious complications in patients undergoing Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of mediastinal masses</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Incidence of bacteremia following EBUS-TBNA biopsy of mediastinal or hilar masses</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>We will determine the proportion of people developing bacteraemia following EBUS-TBNA through performance of blood cultures, to be taken prior to and immediately after performance of EBUS-TBNA. Observation of participants will cease after collection of peripheral blood immediately after the procedure.
The study will be conducted over a six month period.</interventions>
    <comparator>nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>incidence of bacteraemia, as detected by culture of peripheral blood drawn immediately after completion of the procedure</outcome>
      <timepoint>5 minutes following completion of procedure</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of clinically relevant infection, as determined by clinical follow-up, directed by usual physician care.</outcome>
      <timepoint>within 72 hrs of completion of procedure</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients undergoing EBUS-TBNA for investigation of mediastinal and/or hilar masses</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>fever
clinically evident infection (anywhere)
known bacteraemia
antibiotic treatment within 1 week of procedure</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Convenience sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/01/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Daniel Steinfort</primarysponsorname>
    <primarysponsoraddress>c/- Dept Respiratory Medicine
Royal Melbourne Hospital
Grattan St
Parkville 3050</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Daniel Steinfort</fundingname>
      <fundingaddress>c/- Dept Respiratory Medicine
Royal Melbourne Hospital
Grattan St
Parkville
Victoria 3050</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We hypothesize that bacteraemia occurs in a small proportion of people following needle puncture of the tracheal wall during Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of mediastinal lymph nodes.
The purpose of the study is to confirm the proportion, and also to identify the likely bacteriologic agents. This will allow appropriate guidelines of use of antibiotic prophylaxis and choice of empiric antibiotic therapy for those developing clinical infection following EBUS-TBNA</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Melbourne Health Human Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec>2008.239</hrec>
      <ethicsubmitdate>19/11/2008</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Daniel Steinfort</name>
      <address>c/- Dept Respiratory Medicine
Royal Melbourne Hospital
Grattan St
Parkville
Victoria 3050</address>
      <phone>+61 3 9342 7708</phone>
      <fax>+61 3 9342 8493</fax>
      <email>daniel.steinfort@mh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Daniel Steinfort</name>
      <address>c/- Dept Respiratory Medicine
Royal Melbourne Hospital
Grattan St
Parkville
Victoria 3050</address>
      <phone>+61 3 9342 7708</phone>
      <fax>+61 3 9342 8493</fax>
      <email>daniel.steinfort@mh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Daniel Steinfort</name>
      <address />
      <phone />
      <fax>+61 3 9342 8493</fax>
      <email>dsteinfort@yahoo.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>